UTP11 and breast carcinoma: In addition, immunohistochemistry (IHC) staining of UTP11 in 91 breast cancer specimens revealed that higher levels of UTP11 are significantly associated with higher tumor/node/metastasis (TNM) stages and worse overall survival of patients (Fig. 7C and Supplementary Table 2).